A. Zeiher

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
A. M. Zeiher, A. Zeiher, Andreas M. Zeiher, Andreas M Zeiher, Andreas Zeiher, A M Zeiher, Andreas Michael Zeiher, A.m. Zeiher, A Zeiher, Andreas-michael Zeiher
Publication record
898 papers · 102,608 citations · H-index 155

PAPERS

Cell-intrinsic effects of clonal hematopoiesis in heart failure
202334 citationsauthor #7
Aging impairs the neurovascular interface in the heart
202390 citationsauthor #39
Single-nuclear transcriptome profiling identifies persistent fibroblast activation in hypertrophic and failing human hearts of patients with longstanding disease.
202326 citationsauthor #18
LIPOPROTEIN(A) AND CARDIOVASCULAR OUTCOMES IN WOMEN AND MEN AFTER AN ACUTE CORONARY SYNDROME: A POST HOC ODYSSEY OUTCOMES TRIAL ANALYSIS
20230 citationsauthor #12
DNMT3A clonal hematopoiesis-driver mutations induce cardiac fibrosis by paracrine activation of fibroblasts
202348 citationsauthor #19
Omics Analyses of Stromal Cells from ACM Patients Reveal Alterations in Chromatin Organization and Mitochondrial Homeostasis
20234 citationsauthor #9
Mosaic loss of Y chromosome in monocytes is associated with lower survival after transcatheter aortic valve replacement
202343 citationsauthor #7
Transiently achieved very low low-density lipoprotein cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction: the ODYSSEY OUTCOMES trial
202325 citationsauthor #29
Long-term risk associated with clonal hematopoiesis in patients with severe aortic valve stenosis undergoing TAVR
202315 citationsauthor #8
Lipoprotein(a) and the Effect of Alirocumab on Revascularization Following Acute Coronary Syndrome.
20234 citationsauthor #5
Leukocytes carrying Clonal Hematopoiesis of Indeterminate Potential (CHIP) Mutations invade Human Atherosclerotic Plaques
20235 citationsauthor #26
SHORT-DURATION, VERY HIGH-INTENSITY LIPID-LOWERING THERAPY RESULTS IN PROLONGED REDUCTION OF CARDIOVASCULAR EVENTS FOLLOWING ACUTE CORONARY SYNDROME
20230 citationsauthor #14
Improved integration of single cell transcriptome data demonstrated on heart failure in mice and men
20230 citationsauthor #7
Chronic ischemic heart failure is defined by ongoing immune cell activation promoting inflammation and altered crosstalk with endothelial cells
20220 citationsauthor #5
Iatrogenic atrial septal defects after transseptal puncture for percutaneous left atrial appendage occlusion and their hemodynamic effects.
20224 citationsauthor #10
Percutaneous left atrial appendage occlusion in a frail, high-risk, octogenarian patient population, after having undergone transcatheter aortic valve implantation
20222 citationsauthor #10
Relation of red blood cell distribution width to risk of major adverse cardiovascular events, death, and effect of alirocumab after acute coronary syndromes.
20224 citationsauthor #4
Long-term cardiac pathology in individuals with mild initial COVID-19 illness
2022110 citationsauthor #17
Percutaneous coronary intervention for chronic total occlusion in octogenarians: a propensity score study
20222 citationsauthor #5
Abstract 14652: Inherited Genetic Variants in Inflammatory Genes Modulate the Increased Mortality Risk in Patients With HFrEF and Clonal Hematopoiesis
20220 citationsauthor #11
Ageing impairs the neuro-vascular interface in the heart
20220 citationsauthor #27
Low Circulating Musclin is Associated With Adverse Prognosis in Patients Undergoing Transcatheter Aortic Valve Implantation at Low‐Intermediate Risk
20228 citationsauthor #8
Abstract 13063: Clonal Hematopoiesis Associated With TET2 and DNMT3A Gene Driver Mutations Accelerates Aortic Valve Calcification in vitro and in vivo
20220 citationsauthor #12
Abstract 10291: Elevated C-Reactive Protein Level Amplifies the Association of Lipoprotein(a) With Cardiovascular Risk and Risk Reduction With Alirocumab After Acute Coronary Syndrome
20220 citationsauthor #13
Longer leukocyte telomere length is associated with myeloid inflammation and increased mortality after transcatheter aortic valve replacement
20223 citationsauthor #11
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
202273 citationsauthor #18
Abstract 13067: Chronic Ischemic Heart Failure Defines Immune Cell Activation Signatures From ScRNA-seq and Flow Cytometry With Implications for Cardiac Resident Cells
20221 citationsauthor #6
A human cell atlas of the pressure-induced hypertrophic heart
202249 citationsauthor #20
Risk of graft loss in kidney transplant recipients after aortic valve replacement
20221 citationsauthor #8
Alirocumab after acute coronary syndrome in patients with a history of heart failure
20217 citationsauthor #14
Single Nuclei Sequencing Reveals Novel Insights Into the Regulation of Cellular Signatures in Children With Dilated Cardiomyopathy
202140 citationsauthor #16
EFFECTS OF ALIROCUMAB IN PATIENTS WITH RECENT ACS AND A HISTORY OF HEART FAILURE: AN ANALYSIS OF THE ODYSSEY OUTCOMES TRIAL
20210 citationsauthor #15
Angiotensin II receptor blocker intake associates with reduced markers of inflammatory activation and decreased mortality in patients with cardiovascular comorbidities and COVID-19 disease
20217 citationsauthor #28
Additive contribution of microRNA-34a/b/c to human arterial ageing and atherosclerosis.
202133 citationsauthor #17
EFFECTS OF ALIROCUMAB ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH PREVIOUS MYOCARDIAL INFARCTION: SUBANALYSIS FROM THE ODYSSEY OUTCOMES TRIAL
20210 citationsauthor #17
Myocardial Fibrosis and Inflammation by CMR Predict Cardiovascular Outcome in People Living With HIV.
202139 citationsauthor #19
A Novel Method to Predict Mortality and Length of Stay after Transfemoral Transcatheter Aortic Valve Implantation
20216 citationsauthor #4
Chronic ischemic heart failure in humans is associated with changes in expression of antigen processing HLA types and activation of T-cells
20211 citationsauthor #5
SGLT2 inhibitor therapy and pulmonary artery pressure in patients with chronic heart failure—further evidence for improved hemodynamics by continuous pressure monitoring
202112 citationsauthor #3
Clonal Hematopoiesis and Premature Menopause: Unexpected Liaison.
20212 citationsauthor #3
Novel Insights into the Regulation of Cellular Signatures in Children with Dilated Cardiomyopathy
20210 citationsauthor #16
METABOLIC RISK FACTORS AND THE EFFECT OF ALIROCUMAB ON CARDIOVASCULAR EVENTS IN PATIENTS AFTER ACUTE CORONARY SYNDROME: AN ANALYSIS OF THE ODYSSEY OUTCOMES RANDOMIZED CONTROLLED TRIAL
20210 citationsauthor #16
Prevalence of Sleep Disordered Breathing in Patients with Primary Mitral Regurgitation Undergoing Mitral Valve Surgery
20217 citationsauthor #10
Outcomes of cardiovascular magnetic resonance imaging in people living with HIV
20210 citationsauthor #13
Efficacy and Safety of Revacept, a Novel Lesion-Directed Competitive Antagonist to Platelet Glycoprotein VI, in Patients Undergoing Elective Percutaneous Coronary Intervention for Stable Ischemic Heart Disease: The Randomized, Double-blind, Placebo-Controlled ISAR-PLASTER Phase 2 Trial.
202156 citationsauthor #20
Full spectrum of clonal haematopoiesis‐driver mutations in chronic heart failure and their associations with mortality
202135 citationsauthor #12
Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants
202144 citationsauthor #15
Post-myocardial infarction heart failure dysregulates the bone vascular niche
202132 citationsauthor #11
Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial
2020156 citationsauthor #20
EFFECT OF ALIROCUMAB ON FIRST AND TOTAL REVASCULARIZATIONS IN PATIENTS WITH RECENT ACUTE CORONARY SYNDROME IN THE ODYSSEY OUTCOMES TRIAL
20200 citationsauthor #3
Elevated markers of thrombo-inflammatory activation predict outcome in patients with cardiovascular comorbidities and COVID-19 disease: insights from the LEOSS registry
202025 citationsauthor #14
Preserved Th2 lymphocytes improve prognosis of diabetic patients undergoing TAVR
20200 citationsauthor #7
Sub-segmental quantification of single (stress)-pass perfusion CMR improves the diagnostic accuracy for detection of obstructive coronary artery disease
202018 citationsauthor #7
Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19)
20201,914 citationsauthor #10
Potential Role and Prognostic Value of Erythropoietin Levels in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement
20202 citationsauthor #8
Dynamics of cerebral oxygenation during rapid ventricular pacing and its impact on outcome in transfemoral transcatheter aortic valve implantation
202011 citationsauthor #11
3096 – MUTATIONAL LANDSCAPE OF CLONAL HEMATOPOIESIS IN CHRONIC HEART FAILURE PATIENTS WITH DISTINCT RISK GENES FOR INCREASED MORTALITY
20200 citationsauthor #12
Circulating Th17 and Th22 Cells Are Associated With CMR Imaging Biosignatures of Diffuse Myocardial Interstitial Remodeling in Chronic Coronary Artery Disease
20206 citationsauthor #9
Clonal haematopoiesis in chronic ischaemic heart failure: prognostic role of clone size for DNMT3A- and TET2-driver gene mutations.
2020131 citationsauthor #16
Somatic blood cell mutations at low variant allele frequency in distinct risk genes are associated with increased mortality in patients with chronic ischemic heart failure
20202 citationsauthor #11
Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: prespecified analysis from the ODYSSEY OUTCOMES randomized clinical trial
202051 citationsauthor #16
Long telomere length in circulating leukocytes is associated with monocytosis and poorer survival in patients with transcatheter aortic valve replacement
20200 citationsauthor #8
Multiple Somatic Mutations for Clonal Hematopoiesis Are Associated with Increased Mortality in Patients with Chronic Heart Failure.
202047 citationsauthor #14
Efficiency and Target Derepression of Anti-miR-92a: Results of a First in Human Study
2020124 citationsauthor #4
Identification and functional characterization of circular RNAs in pericytes
20200 citationsauthor #6
Incidence, risk factors and prognostic impact of acute kidney injury after coronary angiography and intervention in kidney transplant recipients: a single-center retrospective analysis
20203 citationsauthor #8
Myocardial infarction triggers Inflammatory deterioration of vascular niche by accelerating loss of a specific vessel subtype in bone
20200 citationsauthor #8
Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome.
2020437 citationsauthor #23
Myocardial adaptation as assessed by speckle tracking echocardiography after isolated mitral valve surgery for primary mitral regurgitation
20207 citationsauthor #9
Transcatheter Versus Rapid-Deployment Aortic Valve Replacement: A Propensity-Matched Analysis From the German Aortic Valve Registry.
202032 citationsauthor #12
Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts
2020280 citationsauthor #13
ALIROCUMAB AND CARDIOVASCULAR OUTCOMES IN WOMEN AFTER AN ACUTE CORONARY SYNDROME: AN ODYSSEY OUTCOMES TRIAL ANALYSIS
20205 citationsauthor #17
PRediction of acute coronary syndrome in acute ischemic StrokE (PRAISE) – protocol of a prospective, multicenter trial with central reading and predefined endpoints
202019 citationsauthor #13
Coronavirus Disease 2019 (COVID-19) and its implications for cardiovascular care: expert document from the German Cardiac Society and the World Heart Federation
202064 citationsauthor #5
Sustained Low-Density Lipoprotein Cholesterol Lowering With Alirocumab in ODYSSEY OUTCOMES.
20207 citationsauthor #10
Early hemodynamic changes after transcatheter aortic valve implantation in patients with severe aortic stenosis measured by invasive pressure volume loop analysis
202018 citationsauthor #4
Abstract 15281: Triglyceride Levels and Cardiovascular Outcomes After Acute Coronary Syndrome: Insights From the Odyssey Outcomes Trial
20201 citationsauthor #18
Hemodynamics during transcatheter aortic valve implantation in patients with severe aortic stenosis measured by invasive pressure volume loop analysis
20201 citationsauthor #5
Predicting the outcome of autologous cell therapy on ischemic heart disease; a potential role of risk factors on cell therapy efficacy?
20200 citationsauthor #7
Low-density lipoprotein cholesterol <50 mg/dL is an appropriate target after acute coronary syndrome: propensity score-matched analysis of the ODYSSEY OUTCOMES trial
20200 citationsauthor #13
Clonal Hematopoiesis–Driver DNMT3A Mutations Alter Immune Cells in Heart Failure
2020179 citationsauthor #9
ACHIEVEMENT OF NEW EUROPEAN DYSLIPIDEMIA-GUIDELINE LOW-DENSITY LIPOPROTEIN CHOLESTEROL TREATMENT GOALS AFTER ACUTE CORONARY SYNDROME: INSIGHTS FROM ODYSSEY OUTCOMES
20200 citationsauthor #18
Single cell RNA sequencing reveals profound changes in circulating immune cells in patients with heart failure.
202061 citationsauthor #9
Long Noncoding RNA TYKRIL Plays a Role in Pulmonary Hypertension via the p53-mediated Regulation of PDGFR b
20200 citationsauthor #21
Effects of Post-Myocardial Infarction Heart Failure on the Bone Vascular Niche
20201 citationsauthor #10
Cost-Effectiveness of Alirocumab in Patients With Acute Coronary Syndromes: The ODYSSEY OUTCOMES Trial.
202053 citationsauthor #19
DNMT3A clonal hematopoiesis-driver mutations are associated with profound changes in monocyte and T cell signatures in humans with heart failure
20205 citationsauthor #8
Thirty-day incidence of stroke after transcatheter aortic valve implantation: a meta- and network meta-analysis comparing self-expandable versus balloon-expandable valve prostheses
20200 citationsauthor #6
In-depth phenotyping of cardiac diseases by MRI in HIV-positive people reveals diverse and independent forms of myocardial involvement
20200 citationsauthor #11
Thirty-day incidence of stroke after transfemoral transcatheter aortic valve implantation: meta-analysis and mixt-treatment comparison of self-expandable versus balloon-expandable valve prostheses
202010 citationsauthor #5
Hemodynamic Outcome and Valve Durability Beyond Five Years After Transcatheter Aortic Valve Replacement.
202015 citationsauthor #7
SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes
2020221 citationsauthor #14
The Bioengineered Combo Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Coronary Stent in Patients with Chronic Total Occlusion Evaluated by Clinical Outcome and Optical Coherence Tomography Imaging Analysis
20206 citationsauthor #5
Effect of alirocumab on incidence of atrial fibrillation after acute coronary syndromes: insights from ODYSSEY OUTCOMES
20200 citationsauthor #14
Single nuclei sequencing reveals novel insights into cardiac cell signatures in human pediatric dilated cardiopathy
20201 citationsauthor #8
Myocardial fibrosis and inflammation are predictors of heart failure outcomes in people living with HIV
20200 citationsauthor #11
Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: insights from the ODYSSEY OUTCOMES trial.
202045 citationsauthor #17
Native T1 and T2 provide distinctive signatures in hypertrophic cardiac conditions - Comparison of uremic, hypertensive and hypertrophic cardiomyopathy.
202056 citationsauthor #14
The effect of intracoronary infusion of bone marrow-derived mononuclear cells on all-cause mortality in acute myocardial infarction: the BAMI trial
202058 citationsauthor #18
Value of prognostic nutritional index for survival prediction in trans-catheter aortic valve replacement compared to other common nutritional indexes
202010 citationsauthor #7

TIMELINE

1983 22 citations

1984 23 citations

1985 4 citations

1986 275 citations

1987 63 citations

1988 78 citations

1989 439 citations

1990 7 citations

1991 2,873 citations

1992 14 citations

1993 78 citations

1994 192 citations

1995 1,798 citations

1996 830 citations

1997 2,421 citations

1998 832 citations

1999 5,400 citations

2000 6,326 citations

2001 9,281 citations

2002 3,745 citations

2003 8,515 citations

2004 5,317 citations

2005 8,061 citations

2006 4,651 citations

2007 3,828 citations

2008 1,091 citations

2009 3,057 citations

2010 3,093 citations

2011 2,635 citations

2012 13,045 citations

2013 3,030 citations

2014 877 citations

2015 887 citations

2016 1,025 citations

2017 568 citations

2018 1,299 citations

2019 1,779 citations

2020 4,295 citations

2021 321 citations

2022 257 citations

2023 294 citations

Unknown 37 citations

A. Zeiher

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT